Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

It's ASCO Season: Join Us to Discuss Lung Cancer Highlights on June 28th
Author
Howard (Jack) West, MD

We're heading into the season where much of the biggest news in the cancer world for the year is about to be released, in press releases and full presentations at our annual conference of the American Society for Clinical Oncology (ASCO).  The meeting is June 1-5, in Chicago, and I'll be presenting some of my own work and chairing an educational session on the changing relationships between patients and doctors from the growing knowledge base of patients from online sources.  There will be several other presentations that may well have implications that can change how we practice and offer new treatment options.  

Dr. Joel Neal

Dr. Mark Socinski

On June 28th, at 7 PM Eastern/4 PM Pacific, we're going to have two terrific guest faculty members leading us through the most interesting and important work: Dr. Joel Neal, Assistant Professor in Medical Oncology at Stanford, and Dr. Mark Socinski, Professor and Director of the Lung Cancer Program at the University of Pittsburgh.  Rather than divide by cancer type, we'll see what the most relevant ASCO presentations are and then divide them between our two great speakers.  Each will speak for about 30 minutes, followed by time for a question and answer session with our live audience.

Registration is free: all you need to do to join our ASCO Lung Cancer Highlight webinar is to sign up through this link.  We'll be editing the content of the program to make it available in free podcasts, but you'll want to be there for the live event!

 

 

Next Previous link

Previous PostNext Post

Related Content

Image
Trial data ASCO 2024
Video
In this video series from ASCO 2024, Drs. Aakash Desai and Fauwzi Abu Rous discuss trial dates and clinical data as presented at the 2024 ASCO. To watch the complete playlist, click here.         
Image
Bladder Cancer Video Library 2024
Video
Dr. Petros Grivas discusses intravesical treatment for patients with nonmuscle invasive, or early-stage, bladder cancer, the importance of participating in clinical trials for bladder cancer, combination therapy options for patients with metastatic or incurable bladder cancer, and the importance of family history of cancer and discussing that history with your doctor.
Image
Case Based Panel
Video
The panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and examines data from the Laura Trial, a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions, and a patient with NSCLC adenocarcinoma, and a EGFR Exon 21 L858R Alteration, and how data from the Flaura 2 Trial can impact treatment decisions.

Forum Discussions

Hi elysianfields and welcome to Grace.  I'm sorry to hear about your father's progression. 

 

Unfortunately, lepto remains a difficult area to treat.  Recently FDA approved the combo Lazertinib and Amivantamab...

Hello Janine, thank you for your reply.

Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...

Hi elysianfields,

 

That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...

Recent Comments

JOIN THE CONVERSATION
I could not find any info on…
By JanineT GRACE … on
Hi elysianfields,

 

That's…
By JanineT GRACE … on
Hello Janine, thank you for…
By elysianfields on
EGFR
By happybluesun on